Table 1. Patient characteristics.

Sample	Age (years)	Gender	Histology	Drug	Treatment line	Treatment duration (months)	Best response
MT-002	68	F	Clear Cell	Temsirolimus	Second	8	PR
MT-003	73	M	Clear Cell	Everolimus	Second	8	SD*
MT-004	61	M	Clear Cell	Everolimus	Second	46	PR
MT-005	50	M	Clear Cell	Everolimus	Third	5.5	PR
MT-006	51	F	Clear Cell	Everolimus	Third	11	PR
MT_007	43	M	Chromophobe	Everolimus	First	27.6	CR

*SD: 10% shrinkage